SCHEMBL1013909

SCHEMBL1013909

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1ccc(-c2ccoc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.57
KDM4E B2RXH2 1/20 0.44
CNR1 P21554 1/20 0.43
RXFP1 Q9HBX9 1/20 0.41
NR4A2 P43354 1/20 0.41
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 3/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 2/20 0.40
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.40
CETP P11597 1/20 0.40
SUV39H1 O43463 1/20 0.40
PRMT3 O60678 1/20 0.40
PRMT9 Q6P2P2 1/20 0.40
BCDIN3D Q7Z5W3 1/20 0.40
DOT1L Q8TEK3 1/20 0.40
PRMT1 Q99873 1/20 0.40
SMYD3 Q9H7B4 1/20 0.40
EHMT1 Q9H9B1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015034 0.90 SERPINE1 (0.69) SERPINE1KDM4ECNR1KMT2AALDH1A1
SCHEMBL1015662 0.89 SERPINE1 (0.64) SERPINE1KDM4ECNR1KMT2AALDH1A1
SCHEMBL1016588 0.89 SERPINE1 (0.51) SERPINE1KDM4ECNR1RXFP1ALDH1A1
SCHEMBL1015109 0.88 SERPINE1 (0.57) SERPINE1KDM4ERXFP1NR4A2KMT2A
SCHEMBL1015614 0.88 SERPINE1 (0.57) SERPINE1KDM4ERXFP1NR4A2KMT2A
SCHEMBL420208 0.87 SERPINE1 (0.65) SERPINE1KMT2AALDH1A1MAPTMEN1
SCHEMBL1797516 0.86 ALDH1A1 (0.50) KDM4ERXFP1KMT2AALDH1A1MAPT
SCHEMBL1015454 0.85 ALDH1A1 (0.51) KDM4EKMT2AALDH1A1MAPTMEN1
SCHEMBL1014545 0.85 KDM4E (0.46) KDM4ERXFP1KMT2AALDH1A1MAPT
SCHEMBL1015802 0.82 SERPINE1 (0.84) SERPINE1KDM4ECNR1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885KDM4E 4108/4885CNR1 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.